[Fibrates and risk of venous thromboembolism: Case/no-case study in French pharmacovigilance database].

CONCLUSION: With this study, we confirm the link between VTE and fenofibrate. It is therefore advisable to remain cautious when prescribing fenofibrate, in particular in case of past history of VTE and to declare systematically any venous thromboembolic adverse events observed with these drugs.
PMID: 28941579 [PubMed - as supplied by publisher]

Source: Therapie - August 1, 2017 Category: Psychiatry & Psychology Authors: Humbert X, Dolladille C, Sassier M, Valnet-Rabier MB, Vial T, Guitton E, Page A, Sole E, Auriche P, Coquerel A, Alexandre J, Fedrizzi S Tags: Therapie Source Type: research